Skip to main content

Table 1 Half-wave potentials of HLMWb5 and its site-specific mutants in comparison with various animal cytochrome b5 and their site-specific mutants.

From: Direct electrochemical analyses of human cytochromes b5 with a mutated heme pocket showed a good correlation between their midpoint and half wave potentials

Samples

half-wave potential (mV) (vs. SHE)

Electrode

references

HLMWb5

-19.5

Au*

present study

LMWb5

-21

Au*

[32]

full-length human cyt. b5

-20.5

Au*

present study

L51I

-30.5

Au*

present study

A59V

-29

Au*

present study

A59S

-31.5

Au*

present study

G67A

-40.5

Au*

present study

G67S

-32

Au*

present study

human erythrocyte cyt. b5

-9

Au**

[42]

rat OM cyt. b5 (soluble domain)

+8

Au*

[25]

rat OM cyt. b5 (soluble domain)

-40

Au*+Mg2+

[25]

rat OM cyt. b5 (soluble domain)

-78

Au*+Cr3+

[25]

rat OM cyt. b5 (soluble domain)

-27

Carbon

[28]

DiMe OM cyt. b5 (soluble domain)

+20

Carbon

[28]

V61L/V45L

-14

Carbon

[28]

rat OM cyt. b5 (soluble domain)

-26

ITO

[29]

DiMe OM cyt. b5 (soluble domain)

+4

ITO

[29]

V61I/V45I

-24

ITO

[29]

rat liver cyt. b5 (soluble domain)

+16.2

Au*2

[38]

A67V (soluble domain)

-2.8

Au*2

[38]

rat liver cyt. b5 (soluble domain)

-7

Au*3

[47]

bovine liver cyt. b5 (tryptic fragment)

   

   + 20 mM Mg2+

-6

Au*4

[44]

bovine liver cyt. b5 (tryptic fragment)

   

   + 20 mM Cr(NH3)63+

-14

Au*4

[44]

bovine liver cyt. b5 (tryptic fragment)

-10

Au*3

[18]

V61E (bovine liver, tryptic)

-25

Au*3

[18]

V61Y (bovine liver, tryptic)

-33

Au*3

[18]

V61H (bovine liver, tryptic)

+11

Au*3

[18]

V61K (bovine liver, tryptic)

+17

Au*3

[18]

V45Y

-35

Au*3

[48]

V45H

+8

Au*3

[48]

V45E

-26

Au*3

[48]

  1. The half-wave potentials (E1/2) were measured from respective cyclic voltammogram using various electrodes pre-treated as indicated.
  2. Au*, gold-electrode modified with β-mercaptopropionic acid + poly-L-lysine (200 μM) carbon, DDAB-modified glassy carbon electrode
  3. ITO, indium-doped tin oxide electrode + poly-L-lysine (200 μM)
  4. Au**, gold-electrode modified with KCTCCA peptide
  5. Au*2, gold-electrode modified with HO(CH2)4SH
  6. Au*3, gold-electrode modified with cysteine
  7. Au*4, gold-electrode modified with HSCH2COOH